PROS1 and neoplasm: Recent advancements such as the incorporation of an intracellular scaffolding protein binding site, a PDZ binding domain, to the CAR of CAR-T or -NK cells, have shown improved IS formation and CL polarization, leading in turn to enhanced anti-tumor activity and prolonged survival in several in vivo tumor models including in solid tumors (166).